 Your new post is loading...
|
Scooped by
Ed Rybicki
|
|
Scooped by
Ed Rybicki
|
World Vaccine Congress & Expo 2013 Dr Thomas P. Monath, Adjunct Professor at Harvard School of Public Health gives his presentation on ‘New vaccines needed for pathogens infecting animals and humans: One Health’.
|
Scooped by
Ed Rybicki
|
Infection with influenza virus leads to significant morbidity and mortality. Annual vaccination may prevent subsequent disease by inducing neutralizing antibodies to currently circulating strains in the human population. To escape this antibody response, influenza A viruses undergo continuous genetic variation as they replicate, enabling viruses with advantageous antigenic mutations to spread and cause disease in naïve or previously immune or vaccinated individuals. To date, the 2009 pandemic virus (A(H1N1)pdm09) has not undergone significant antigenic drift, with the result that the vaccine remains well-matched and should provide good protection to A(H1N1)pdm09 circulating viruses. In this study, we induced antigenic drift in an A(H1N1)pdm09 virus in the ferret model. A single amino acid mutation emerged in the dominant surface glycoprotein, hemagglutinin, which had a multifaceted effect, altering both antigenicity and virus receptor specificity. The mutant virus could not be isolated using routine cell culture methods without the virus acquiring additional amino acid changes, yet was fit in vivo. The implications for surveillance of circulating influenza virus are significant as current assays commonly used to assess vaccine mismatch, as well as to produce isolates for vaccine manufacture, are biased against identification of viruses containing only this mutation. Influenza virus graphic by Russell Kightley Media
|
Scooped by
Ed Rybicki
|
Water birds, to an influenza researcher, are more than majestic swans and charming mallards. They are instead stealthy vectors of novel influenza viruses, some of nature’s bioterrorist agents, chauffeuring dangerous microbes from place to place without showing symptoms of infection themselves. Wild waterfowl are reservoirs for every imaginable combination of influenza viruses, though the vast majority of those viral cocktails don’t seem to infect humans.
|
Scooped by
Ed Rybicki
|
Imgur is used to share photos with social networks and online communities, and has the funniest pictures from all over the Internet.
|
Scooped by
Ed Rybicki
|
Human influenza infections exhibit a strong seasonal cycle in temperate regions. Recent laboratory and epidemiological evidence suggests that low specific humidity conditions facilitate the airborne survival and transmission of the influenza virus in temperate regions, resulting in annual winter epidemics. However, this relationship is unlikely to account for the epidemiology of influenza in tropical and subtropical regions where epidemics often occur during the rainy season or transmit year-round without a well-defined season. We assessed the role of specific humidity and other local climatic variables on influenza virus seasonality by modeling epidemiological and climatic information from 78 study sites sampled globally. We substantiated that there are two types of environmental conditions associated with seasonal influenza epidemics: “cold-dry” and “humid-rainy”. For sites where monthly average specific humidity or temperature decreases below thresholds of approximately 11–12 g/kg and 18–21°C during the year, influenza activity peaks during the cold-dry season (i.e., winter) when specific humidity and temperature are at minimal levels. For sites where specific humidity and temperature do not decrease below these thresholds, seasonal influenza activity is more likely to peak in months when average precipitation totals are maximal and greater than 150 mm per month. These findings provide a simple climate-based model rooted in empirical data that accounts for the diversity of seasonal influenza patterns observed across temperate, subtropical and tropical climates.
|
Scooped by
Ed Rybicki
|
When U.S. public health agencies acknowledge the limitations of the influenza vaccine – which they do much less often than they should – they tend to use a phrase like “less than perfect.” “Less than adequate” would capture the situation better.
|
|
Scooped by
Ed Rybicki
|
The 2009 swine-origin H1N1 influenza, though antigenically novel to the population at the time, was antigenically similar to the 1918 H1N1 pandemic influenza, and consequently was considered to be [ldquo]archived[rdquo] in the swine species before reemerging in humans. Given that the H3N2 is another subtype that currently circulates in the human population and is high on WHO pandemic preparedness list, we assessed the likelihood of reemergence of H3N2 from a non-human host. Using HA sequence features relevant to immune recognition, receptor binding and transmission we have identified several recent H3 strains in avian and swine that present hallmarks of a reemerging virus. IgG polyclonal raised in rabbit with recent seasonal vaccine H3 fail to recognize these swine H3 strains suggesting that existing vaccines may not be effective in protecting against these strains.
Vaccine strategies can mitigate risks associated with a potential H3N2 pandemic in humans.
|
Scooped by
Ed Rybicki
|
Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
Influenza in birds graphic from Russell Kightley Media
|
Scooped by
Ed Rybicki
|
TORONTO — Making a vaccine to protect against the new bird flu virus that has emerged in eastern China could prove to be problematic, influenza experts acknowledged yesterday.
|
Scooped by
Ed Rybicki
|
GlaxoSmithKline’s quadrivalent influenza vaccine has been granted marketing authorisation in Germany and the UK. The four-strain vaccine is the first to be approved in a European country for active immunisation of adults and children from three years of age for the prevention of influenza disease caused by the two influenza A and two influenza B virus subtypes contained within the vaccine.
|
Scooped by
Ed Rybicki
|
I am TRYING to write an eBook on influenza, which stubbornly refuses to be finished - as part of a sabbatical project, which finished in December 2010. So, like my History of Virology, I am triall...
|
Scooped by
Ed Rybicki
|
Geographic variables play an important role in the study of epidemics. The role of one such variable, population density, in the spread of influenza is controversial.
Prior studies have tested for such a role using arbitrary thresholds for population density above or below which places are hypothesized to have higher or lower mortality. The results of such studies are mixed.
The objective of this study is to estimate, rather than assume, a threshold level of population density that separates low-density regions from high-density regions on the basis of population loss during an influenza pandemic. We study the case of the influenza pandemic of 1918--19 in India, where over 15 million people died in the short span of less than one year. Pandemic recombinant influenza virus graphic from Russell Kightley Media
Animation of the mechanism of an influenza virus and how Crucell's antibodies target the HA1 proteins on the virus and prevent further spread of influenza. Might be an advert, but it's one of the nicest animations of flu virus entry and neutralisation that I've ever seen. In fact, it's the ONLY one!
|
Great: so now they have to worry about distressed bats, as well as flodding??